← Search

Excel · study · 2026

Immune Activation and Candidate Prognostic Marker Discovery in Bladder Cancer: A Preclinical Mouse Study of Recombinant M. smegmatis

Listed in NCBI GEO

This study investigated transcriptomic alterations associated with rSmeg-hMIF-hIL-7 treatment in a syngeneic MBT-2 bladder cancer mouse model.

Description

Female C3H/He mice bearing subcutaneous MBT-2 tumors received either PBS or rSmeg-hMIF-hIL-7 by intraperitoneal injection every other day. Tumor tissues were subjected to bulk RNA sequencing to characterize treatment-associated gene-expression changes and biological pathways related to immune activation, apoptosis, angiogenesis, cell adhesion, and tumor progression.

A total of seven tumor samples were sequenced. The deposited dataset contains four PBS control samples and three rSmeg-hMIF-hIL-7-treated samples.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 75% · RNA sequencing 75% · Sequencing 75%
Provenance · 1 source records, 10 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34386614 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[organism].NCBITaxon:10090source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title